» Articles » PMID: 33804453

Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease-Apart or Together?

Overview
Journal Nutrients
Date 2021 Apr 3
PMID 33804453
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin K (VK) and vitamin D (VD) deficiency/insufficiency is a common feature of chronic kidney disease (CKD), leading to impaired bone quality and a higher risk of fractures. CKD patients, with disturbances in VK and VD metabolism, do not have sufficient levels of these vitamins for maintaining normal bone formation and mineralization. So far, there has been no consensus on what serum VK and VD levels can be considered sufficient in this particular population. Moreover, there are no clear guidelines how supplementation of these vitamins should be carried out in the course of CKD. Based on the existing results of preclinical studies and clinical evidence, this review intends to discuss the effect of VK and VD on bone remodeling in CKD. Although the mechanisms of action and the effects of these vitamins on bone are distinct, we try to find evidence for synergy between them in relation to bone metabolism, to answer the question of whether combined supplementation of VK and VD will be more beneficial for bone health in the CKD population than administering each of these vitamins separately.

Citing Articles

Effects of the Interaction between Dietary Vitamin D and Vitamin K on Growth, Skeletal Anomalies, and Expression of Bone and Calcium Metabolism-Related Genes in Juvenile Gilthead Seabream ().

Sivagurunathan U, Izquierdo M, Tseng Y, Prabhu P, Zamorano M, Robaina L Animals (Basel). 2024; 14(19).

PMID: 39409757 PMC: 11475414. DOI: 10.3390/ani14192808.


Nutritional therapy bridges the critical cut-off point for the closed-loop role of type 2 diabetes and bone homeostasis: A narrative review.

Zeng J, Qian Y, Yang J, Chen X, Fu C, Che Z Heliyon. 2024; 10(7):e28229.

PMID: 38689978 PMC: 11059410. DOI: 10.1016/j.heliyon.2024.e28229.


Zinc, Magnesium and Vitamin K Supplementation in Vitamin D Deficiency: Pathophysiological Background and Implications for Clinical Practice.

Bleizgys A Nutrients. 2024; 16(6).

PMID: 38542745 PMC: 10974675. DOI: 10.3390/nu16060834.


Vitamin D and Its Receptors in Cervical Cancer.

Dong H, Chen S, Liang X, Cai Q, Zhang X, Xie J J Cancer. 2024; 15(4):926-938.

PMID: 38230221 PMC: 10788714. DOI: 10.7150/jca.87499.


Effects of Isoflavonoid and Vitamin D Synergism on Bone Mineral Density-A Systematic and Critical Review.

Miedziaszczyk M, Maciejewski A, Idasiak-Piechocka I, Karczewski M, Lacka K Nutrients. 2023; 15(24).

PMID: 38140273 PMC: 10745652. DOI: 10.3390/nu15245014.


References
1.
Gois P, Wolley M, Ranganathan D, Seguro A . Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies. Int J Environ Res Public Health. 2018; 15(8). PMC: 6121405. DOI: 10.3390/ijerph15081773. View

2.
Deluca H . History of the discovery of vitamin D and its active metabolites. Bonekey Rep. 2014; 3:479. PMC: 3899558. DOI: 10.1038/bonekey.2013.213. View

3.
Poon C, Li R, Seto S, Kong S, Ho H, Hoi M . In vitro vitamin K(2) and 1α,25-dihydroxyvitamin D(3) combination enhances osteoblasts anabolism of diabetic mice. Eur J Pharmacol. 2015; 767:30-40. DOI: 10.1016/j.ejphar.2015.09.048. View

4.
Shea M, Booth S, Massaro J, Jacques P, DAgostino Sr R, Dawson-Hughes B . Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2007; 167(3):313-20. PMC: 3151653. DOI: 10.1093/aje/kwm306. View

5.
Terry A, Sandrock T, Meikle A . Measurement of 25-hydroxyvitamin D by the Nichols ADVANTAGE, DiaSorin LIAISON, DiaSorin RIA, and liquid chromatography-tandem mass spectrometry. Clin Chem. 2005; 51(8):1565-6. DOI: 10.1373/clinchem.2005.054239. View